Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Shares Outstanding (Weighted Average): 2013-2017

Historic Shares Outstanding (Weighted Average) for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2017 value amounting to $905,791.

  • Tvardi Therapeutics' Shares Outstanding (Weighted Average) rose 19.52% to $905,791 in Q4 2017 from the same period last year, while for Sep 2017 it was $905,041, marking a year-over-year increase of 19.42%. This contributed to the annual value of $1.5 million for FY2024, which is 0.69% up from last year.
  • According to the latest figures from Q4 2017, Tvardi Therapeutics' Shares Outstanding (Weighted Average) is $905,791, which was up 0.08% from $905,041 recorded in Q3 2017.
  • Tvardi Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $905,791 for Q4 2017, and its period low was $606,734 during Q3 2013.
  • In the last 3 years, Tvardi Therapeutics' Shares Outstanding (Weighted Average) had a median value of $757,857 in 2016 and averaged $773,496.
  • Data for Tvardi Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY rose of 19.96% (in 2015) over the last 5 years.
  • Tvardi Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $606,734 in 2013, then increased by 4.29% to $632,738 in 2014, then rose by 19.55% to $756,432 in 2015, then increased by 0.19% to $757,857 in 2016, then grew by 19.52% to $905,791 in 2017.
  • Its Shares Outstanding (Weighted Average) was $905,791 in Q4 2017, compared to $905,041 in Q3 2017 and $902,985 in Q2 2017.